«

»

First Ever Topical Gene Therapy Approved For “Butterfly Disease” Children

Categories:

Forbes, healthcare

May 24, 2023

by Greg Licholai, MD, Contributor

Topical gene therapy VYJUVEK approved Butterfly Disease Epidermolysis Bullosa Beremagene Geperpavec (B-VEC) EBRP

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive